How many classification rules does the EU MDR have?

The EU MDR contains 22 classification rules in Annex VIII, organized into four categories: non-invasive devices (Rules 1–4), invasive devices (Rules 5–8), active devices (Rules 9–13), and special rules (Rules 14–22). Each rule assigns a device to Class I, IIa, IIb, or III based on its intended purpose, duration of use, invasiveness, and potential risk to the patient.

What is the difference between Class IIa and Class IIb under EU MDR?

Class IIa devices present medium risk (e.g., hearing aids, surgical clamps, dental crowns), while Class IIb devices present medium-high risk (e.g., ventilators, infusion pumps, condoms, X-ray machines). The key differences lie in conformity assessment rigor: Class IIb requires more extensive Notified Body review of technical documentation. Classification depends on factors like duration of use, invasiveness level, whether the device delivers energy to the body, and whether it administers or removes medicines or body fluids.

Did device classifications change from MDD to MDR?

Yes, many devices were up-classified from the Medical Device Directive (MDD) to the MDR. Notable examples include: reusable surgical instruments (now Class Ir requiring NB involvement), software intended to drive clinical decisions (often moved from Class I to IIa or IIb under Rule 11), devices containing nanomaterials (typically Class III under Rule 19), and devices composed of substances absorbed by the body (often Class III under Rule 21). Manufacturers must verify their device’s classification under MDR Annex VIII rules, as assuming the same class as under MDD can lead to non-compliance.

Can a medical device fall under multiple classification rules?

Yes. When multiple rules apply to the same device, the strictest rule (i.e., the one that assigns the highest class) takes precedence. This is known as the ‘highest class’ principle. For example, an active device that is also invasive may be evaluated under both invasive and active device rules, and the resulting classification will be the higher of the two outcomes.

How does EU MDR classification affect tender eligibility?

Classification directly determines the conformity assessment route, which in turn determines what documentation a procurement team will require. Higher-class devices need more extensive Notified Body involvement, PMCF plans, and potentially a Summary of Safety and Clinical Performance (SSCP). In tenders, misclassification means your CE certificate may reference the wrong conformity assessment Annex, leading to bid rejection. MedStrato automatically cross-checks device classification against tender requirements to flag mismatches before submission.

← Journal

法规合规

EU MDR Classification Rules: How to Classify Your Medical Device [2026 Guide]

2026年5月16日

Getting your EU MDR device classification right is the single most important regulatory decision you’ll make. It determines your conformity assessment route, Notified Body involvement, clinical evidence requirements, post-market obligations, and ultimately whether you can legally sell your device in the European Union. Get it wrong and you risk regulatory delays, rejected tender bids, and potential enforcement action.

This guide walks you through all 22 classification rules in MDR Annex VIII, grouped by category, with practical examples and a decision-tree approach you can apply immediately.

What MDR Classification Means and Why It Matters for Market Access

Under the EU Medical Device Regulation (2017/745), every medical device must be assigned to one of four risk classes: Class I (lowest risk), Class IIa (medium risk), Class IIb (medium-high risk), or Class III (highest risk). This classification is not arbitrary — it’s determined by applying the 22 rules in Annex VIII to your device’s intended purpose.

Classification drives everything downstream:

Conformity assessment procedure — Class I devices can self-declare (with exceptions); Class IIa+ require a Notified Body
Clinical evidence level — higher classes demand more robust clinical data and may require clinical investigations
Post-market surveillance intensity — Class III and implantables need PMCF studies and Periodic Safety Update Reports
Tender eligibility — procurement teams verify that your CE certificate matches the correct classification and conformity assessment Annex
Timeline to market — higher classes mean longer Notified Body queues (currently 12–18 months for Class III)

Overview of the 4 Classes

Class	Risk Level	Examples	Notified Body?
Class I	Lowest	Bandages, tongue depressors, hospital beds, non-sterile wheelchairs	No (except Is, Im, Ir)
Class IIa	Medium	Hearing aids, dental crowns, ultrasound probes, suction equipment	Yes
Class IIb	Medium-high	Ventilators, infusion pumps, blood bags, external defibrillators	Yes
Class III	Highest	Heart valves, hip implants, drug-eluting stents, breast implants	Yes + clinical scrutiny for some

Note the sub-categories within Class I: sterile devices (Is), devices with a measuring function (Im), and reusable surgical instruments (Ir) require Notified Body involvement for specific aspects even though they remain Class I.

The 22 Rules of Annex VIII: Non-Invasive Devices (Rules 1–4)

Non-invasive devices are those that do not penetrate the body through a body orifice or through the body surface. The default classification is Class I unless specific criteria elevate the risk.

Rule 1 — Devices that do not touch the patient or contact only intact skin: Class I. Examples: hospital beds, patient transport equipment, stethoscopes, wound dressings for intact skin.

Rule 2 — Devices intended to channel or store blood, body fluids, cells, or tissues for transfusion/infusion/transplantation: Class IIa if for storage/channeling only; Class IIb if connected to a Class IIa or higher active device; Class III if for blood bags. Example: blood storage bags (Class III), IV tubing sets (Class IIa).

Rule 3 — Devices that modify the biological or chemical composition of human tissues, cells, blood, or other body fluids intended for infusion/transplantation: Class IIb. If treatment consists of filtration, centrifugation, or gas/heat exchange: Class IIa. Examples: blood cell separators (IIa), dialysis concentrates (IIb).

Rule 4 — Devices that come into contact with injured skin: Class I if mechanical barrier/compression/absorption of exudates; Class IIb if used with wounds breaching the dermis and healing only by secondary intent; Class IIa for all other wound management devices. Examples: gauze dressings (I), hydrocolloid dressings for chronic wounds (IIb), adhesive plasters for surgical wounds (IIa).

Invasive Devices (Rules 5–8)

Invasive devices penetrate the body through a body orifice or through the body surface. Classification depends on duration of use: transient (<60 min), short-term (≤30 days), or long-term (>30 days).

Rule 5 — Invasive devices related to body orifices (non-surgically invasive): transient use → Class I; short-term use → Class IIa; long-term use → Class IIb; connected to active device in Class IIa or higher → Class IIa. Examples: dental impression materials (I), urinary catheters for short-term (IIa), intrauterine devices (IIb).

Rule 6 — Surgically invasive devices intended for transient use: generally Class IIa. Elevated to Class IIb if intended to supply energy (in form other than from active device), administer medicines, or diagnose/monitor/correct a defect of the heart. Class III if in direct contact with the CNS or heart, or if reusable surgical instruments. Examples: surgical sutures (IIa), surgical needles (IIa), cardiovascular catheters (III).

Rule 7 — Surgically invasive devices for short-term use: generally Class IIa. Elevated to Class IIb if intended to supply energy or administer medicines. Class III if intended for use in direct contact with the heart, CNS, or central circulatory system, or intended to undergo chemical change, administer medicines, or have a biological effect. Examples: surgical clamps for short-term (IIa), infusion cannulae (IIb), temporary pacemaker electrodes (III).

Rule 8 — Implantable and long-term surgically invasive devices: generally Class IIb. Elevated to Class III if placed in contact with the heart, CNS, or central circulatory system; if intended to have a biological effect or be absorbed; if intended to administer medicines; or if active implantable devices. Examples: hip joints (III), dental implants (IIb), cochlear implants (III), intraocular lenses (IIb).

Active Devices (Rules 9–13)

Active devices rely on a source of energy other than that generated directly by the human body or gravity.

Rule 9 — Active therapeutic devices intended to deliver or exchange energy: Class IIa unless characteristics of energy delivered could be dangerous → Class IIb. Examples: TENS devices (IIa), surgical lasers (IIb), radiotherapy equipment (IIb).

Rule 10 — Active devices intended for diagnosis and monitoring: Class IIa for devices supplying energy to image the body or monitoring vital physiological parameters where variations could result in danger. Class IIb if specifically monitoring vital parameters where variations could result in immediate danger to the patient. Class I for all other active diagnostic devices. Examples: MRI scanners (IIa), blood pressure monitors (IIa), ICU vital signs monitors (IIb).

Rule 11 — Software: software intended to provide information used for diagnostic or therapeutic decisions is classified as Class IIa, except if decisions may cause death or irreversible deterioration → Class III, or serious deterioration → Class IIb. All other software is Class I. This rule is one of the most significant changes from MDD, as many software products previously unregulated or in Class I are now Class IIa or IIb.

Rule 12 — Active devices intended to administer and/or remove medicinal products or other substances to/from the body: Class IIa unless done in a potentially hazardous manner → Class IIb. Examples: infusion pumps (IIb), nebulizers (IIa).

Rule 13 — All other active devices: Class I. Examples: active devices for patient positioning, examination lights.

Special Rules (Rules 14–22)

These rules address specific device types that don’t fit neatly into the previous categories or that warrant higher classification due to particular risks.

Rule 14 — Devices incorporating a medicinal substance as integral part: Class III. Examples: drug-eluting stents, antibiotic-loaded bone cement.

Rule 15 — Devices used for contraception or prevention of sexually transmitted diseases: Class IIb; Class III if implantable or long-term invasive. Examples: condoms (IIb), contraceptive diaphragms (IIb), hormone-releasing IUDs (III).

Rule 16 — Devices specifically intended for disinfecting/sterilizing medical devices: Class IIa for cleaning/disinfection by physical action; Class IIb for disinfectants acting on invasive devices as endpoint. Examples: washer-disinfectors (IIa), high-level disinfectant solutions (IIb).

Rule 17 — Devices specifically intended for recording diagnostic images generated by X-ray: Class IIa. Examples: X-ray film, digital imaging plates.

Rule 18 — Devices utilizing non-viable tissues or cells of human origin (or derivatives): Class III. Examples: human bone grafts, acellular dermal matrices of human origin.

Rule 19 — Devices incorporating or consisting of nanomaterials: Class III if high/medium internal exposure potential; Class IIb if low internal exposure; Class IIa if negligible. This is a new MDR rule with no MDD equivalent.

Rule 20 — Invasive devices with respect to body orifices (non-surgically) that administer medicines by inhalation: Class IIa unless mode of action has essential impact on efficacy/safety → Class IIb. Examples: simple spacers for inhalers (IIa), nebulizer-drug combinations (IIb).

Rule 21 — Devices composed of substances introduced into the body via a body orifice or the skin and that are absorbed by or locally dispersed in the body: Class III. Examples: dermal fillers, degradable wound closure materials applied internally.

Rule 22 — Active therapeutic devices with an integrated or built-in diagnostic function which significantly determines patient management: Class III. Examples: automated external defibrillators with diagnostic algorithm determining shock delivery, closed-loop insulin delivery systems.

Decision Tree Approach to Classification

Rather than reading all 22 rules sequentially, use this systematic approach:

Step 1: Is the device active? If yes, evaluate Rules 9–13 first. If it’s software, go directly to Rule 11.
Step 2: Is the device invasive? Determine if surgically or non-surgically invasive, and the duration of use (transient, short-term, long-term). Apply Rules 5–8.
Step 3: Is the device non-invasive? Apply Rules 1–4 based on what the device contacts or modifies.
Step 4: Do any special rules apply? Check Rules 14–22 for nanomaterials, medicinal substances, human tissue, contraception, disinfection, etc.
Step 5: Apply the highest-class principle. If multiple rules apply, the highest resulting class wins.

Document your classification rationale in your technical documentation — auditors and Notified Bodies will review this during conformity assessment.

Common Reclassification Pitfalls: MDD to MDR

Many manufacturers have been caught off guard by devices moving to a higher class under MDR. The most common reclassifications include:

Software (Rule 11) — Clinical decision support software that was Class I or unregulated under MDD is now often Class IIa or IIb. Some diagnostic software triggering treatment for life-threatening conditions is Class III.
Reusable surgical instruments (Rule 6/Class Ir) — Still Class I but now require Notified Body involvement for reprocessing validation aspects.
Nanomaterial-containing devices (Rule 19) — Entirely new rule; devices previously classified lower under MDD rules are now potentially Class III.
Devices composed of absorbed substances (Rule 21) — Dermal fillers, for example, moved from Class IIb/III under MDD to mandatory Class III.
Devices with diagnostic function determining therapy (Rule 22) — New rule elevating closed-loop systems to Class III.

If your device has been reclassified upward, you need a Notified Body where previously you may not have, your clinical evidence requirements increase, and your conformity assessment route changes entirely.

Impact on Conformity Assessment Route

Classification determines which conformity assessment Annexes apply:

Class	Conformity Assessment Route	NB Involvement
Class I	Annex IV (self-declaration) + Annex V (QMS) for Is/Im/Ir aspects	Only for sterile, measuring, or reusable aspects
Class IIa	Annex IX (full QMS) or Annex XI Part A + product check	Yes — QMS audit + technical documentation sampling
Class IIb	Annex IX (full QMS) + Annex X (type examination) for implantables	Yes — full QMS audit + technical documentation review per device
Class III	Annex IX (full QMS) + Annex X (type examination)	Yes — full audit + full technical documentation review + clinical scrutiny for some

How Classification Affects Tender Eligibility

Correct classification isn’t just a regulatory formality — it directly impacts your ability to win tenders:

CE certificate must match — Procurement teams verify that your Notified Body certificate references the correct MDR Annex for your device class. A mismatch triggers an immediate compliance question.
Documentation expectations scale with class — A Class III device bid without an SSCP (Summary of Safety and Clinical Performance) will be rejected. Class IIb+ devices may require PMCF data in tender submissions.
Reclassified devices are under scrutiny — Hospital procurement teams are aware of the MDD-to-MDR reclassification wave. They specifically check whether software or nano-containing devices hold correct MDR certificates, not legacy MDD ones.
Timeline implications — If your device was reclassified and you’re still waiting for your Notified Body to complete the higher-class conformity assessment, you may be ineligible for tenders until the certificate is issued.

MedStrato’s automated compliance engine verifies device classification against tender requirements in real time, flagging mismatches before you submit your bid.

Next Steps

Classification is the foundation of your EU MDR compliance strategy. Once you know your class, you can plan your conformity assessment route, select a Notified Body with appropriate designation scope, and prepare the correct documentation package for tender responses.

For a broader overview of the EU MDR framework, see our complete EU MDR guide. To understand how classification feeds into the risk classification requirements that procurement teams verify, explore our glossary.

Ready to automate regulatory compliance checking in your tender workflow? Book a demo to see MedStrato in action.